2616
COM:CSTONEPHARMA
CStone Pharmaceuticals Co Ltd
- Stock
Last Close
1.96
25/11 03:32
Market Cap
1.57B
Beta: -
Volume Today
1.52M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | -253.04M - | -342.55M 35.37% | -1.79B 423.47% | -2.31B 28.74% | -1.22B 47.11% | -1.92B 57.26% | -902.68M 52.99% | -367.23M 59.32% | |
depreciation and amortization | 69K - | 821K 1,089.86% | 5.27M 541.41% | 11.58M 119.90% | 14.80M 27.82% | 22.66M 53.10% | 44.54M 96.55% | 58.19M 30.65% | |
deferred income tax | -9.27M - | 103.52M 1,216.35% | 741.98M 616.76% | 637.37M 14.10% | 179.42M 71.85% | 134.24M 25.18% | |||
stock based compensation | 9.37M - | 28.09M 199.83% | 234.96M 736.52% | 410.72M 74.80% | 356.02M 13.32% | 222.67M 37.46% | 142.06M 36.20% | 36.99M 73.96% | |
change in working capital | 39.73M - | -26.62M 167.00% | 27.88M 204.73% | 235.83M 745.97% | 185.98M 21.14% | 64.52M 65.31% | 72.65M 12.60% | -140.81M 293.83% | |
accounts receivables | -117.60M - | 40.47M 134.41% | |||||||
inventory | -61.36M - | 30.42M 149.57% | -95.46M 413.83% | ||||||
accounts payables | 117.60M - | -40.47M 134.41% | |||||||
other working capital | 125.88M - | 42.23M 66.45% | |||||||
other non cash items | 141K - | -3.45M 2,545.39% | -8.06M 133.82% | -67.77M 740.61% | -23.29M 65.63% | -8.01M 65.61% | 30.96M 486.47% | -21.31M 168.84% | |
net cash provided by operating activities | -213.01M - | -240.19M 12.76% | -791.11M 229.37% | -1.08B 36.61% | -508.07M 52.99% | -1.48B 192.09% | -612.47M 58.73% | -588.84M 3.86% | |
investments in property plant and equipment | -1.11M - | -12.51M 1,025.27% | -7.91M 36.82% | -10.43M 31.90% | -71.45M 585.14% | -149.14M 108.74% | -101.82M 31.73% | -65.05M 36.12% | |
acquisitions net | -55K - | 5.68M 10,436.36% | 4.28M 24.80% | 38.52M 800.98% | 18.46M 52.08% | -48.42M 362.34% | |||
purchases of investments | -767.88M - | -3.74B 387.45% | -1.04B 72.13% | -1.61B 53.90% | -358.87M 77.65% | -1.05B 192.87% | -683.41M 34.98% | -67.78M 90.08% | |
sales maturities of investments | 15.48M - | 4.02B 25,858.18% | 664.67M 83.46% | 919.33M 38.31% | 1.59B 73.16% | 363.54M 77.16% | 1.15B 215.57% | 515.47M 55.07% | |
other investing activites | 99K - | 369K 272.73% | 4.34M 1,075.07% | -961K 122.16% | 671K 169.82% | 58.48M 8,615.50% | 3.13M 94.64% | ||
net cash used for investing activites | -753.47M - | 268.30M 135.61% | -377.70M 240.78% | -658.88M 74.45% | 1.18B 279.20% | -826.55M 170.00% | 365.12M 144.17% | 619.61M 69.70% | |
debt repayment | -4.68M - | -1.58M 66.26% | -6.71M 324.43% | -32M 377.18% | -91.43M 185.73% | ||||
common stock issued | 2.61M - | 2.20B - | 1.36B 38.07% | 16.83M 98.76% | 2.53M 84.97% | 341.82M 13,416.17% | |||
common stock repurchased | -21.80M - | ||||||||
dividends paid | |||||||||
other financing activites | 1.01B - | -300K 100.03% | 1.66B 554,240% | -101.50M 106.11% | 51.88M 151.11% | 82.18M 58.40% | 57.94M 29.50% | ||
net cash used provided by financing activities | 1.01B - | -300K 100.03% | 1.66B 554,240% | 2.09B 25.80% | 1.39B 33.56% | 92.30M 93.36% | 28.47M 69.16% | 388.36M 1,264.23% | |
effect of forex changes on cash | 15.51M - | -3.96M 125.55% | 124.33M 3,237.37% | 73.37M 40.99% | -163.98M 323.48% | -63.55M 61.24% | 34.84M 154.83% | 18.87M 45.84% | |
net change in cash | 59.54M - | 23.85M 59.94% | 617.95M 2,490.86% | 425.10M 31.21% | 1.90B 346.51% | -2.28B 220.22% | -184.04M 91.93% | 437.99M 337.98% | |
cash at beginning of period | 59.54M - | 83.39M 40.06% | 701.34M 741.03% | 1.13B 60.61% | 3.02B 168.51% | 742.72M 75.44% | 558.68M 24.78% | ||
cash at end of period | 59.54M - | 83.39M 40.06% | 701.34M 741.03% | 1.13B 60.61% | 3.02B 168.51% | 742.72M 75.44% | 558.68M 24.78% | 996.67M 78.40% | |
operating cash flow | -213.01M - | -240.19M 12.76% | -791.11M 229.37% | -1.08B 36.61% | -508.07M 52.99% | -1.48B 192.09% | -612.47M 58.73% | -588.84M 3.86% | |
capital expenditure | -1.11M - | -12.51M 1,025.27% | -7.91M 36.82% | -10.43M 31.90% | -71.45M 585.14% | -149.14M 108.74% | -101.82M 31.73% | -65.05M 36.12% | |
free cash flow | -214.12M - | -252.70M 18.02% | -799.01M 216.19% | -1.09B 36.56% | -579.52M 46.89% | -1.63B 181.81% | -714.29M 56.26% | -653.89M 8.46% |
All numbers in (except ratios and percentages)